Petrol, Diesel Prices Unchanged On Thursday
Petrol and diesel rates were left unchanged at existing levels on Thursday i.e. November 5. That marked around a month of no change in the prices of petrol in different parts of the country, and about six weeks in case of diesel. In Delhi, the price of petrol remained at Rs 81.06 per litre, and diesel at Rs 70.46 per litre on November 4, according to Indian Oil Corporation notifications. In Mumbai, the rates were Rs 87.74 per litre and Rs 76.86 per litre respectively. (Also Read: How To Find Latest Petrol, Diesel Rates In Your City)
Here are the prices of petrol and diesel in the four metros (in rupees per litre) on Tuesday, November 3:
| City | Petrol | Diesel |
|---|---|---|
| Delhi | 81.06 | 70.46 |
| Mumbai | 87.74 | 76.86 |
| Chennai | 84.14 | 75.95 |
| Kolkata | 82.59 | 73.99 |
| Source: Indian Oil | ||
Currently, petrol and diesel prices vary in different parts of the country due to local taxes. State-run oil marketing companies Indian Oil Corporation, Bharat Petroleum Corporation and Hindustan Petroleum Corporation - which account for the majority of fuel stations in the country -Â review the fuel rates on a daily basis.
The three implement any changes in domestic fuel prices with effect from 6 am, aligning them with crude oil and rupee-dollar forex rates.
Meanwhile, oil prices fell in early trade on Thursday as the dollar strengthened on expectations the Republican Party would keep control of the Senate following the U.S. election, holding back any huge COVID-19 relief package.
U.S. West Texas Intermediate (WTI) crude futures dropped 29 cents, or 0.7 per cent, to $38.86 a barrel at 0042 GMT. Brent crude futures had yet to start trading. Both benchmark contracts jumped around 4 per cent on Wednesday.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.